Sean Lee
Stock Analyst at HC Wainwright & Co.
(4.13)
# 499
Out of 5,124 analysts
98
Total ratings
34.74%
Success rate
23.73%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KZIA Kazia Therapeutics | Maintains: Buy | $13 → $18 | $5.00 | +260.00% | 6 | Dec 12, 2025 | |
| CTSO Cytosorbents | Maintains: Neutral | $1 → $0.75 | $0.66 | +14.36% | 14 | Nov 14, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $1.4 → $19 | $5.89 | +214.09% | 3 | Nov 6, 2025 | |
| PSTV Plus Therapeutics | Maintains: Buy | $3 → $2 | $0.56 | +260.36% | 13 | Nov 3, 2025 | |
| ATEC Alphatec Holdings | Maintains: Buy | $20 → $24 | $20.76 | +15.61% | 13 | Oct 31, 2025 | |
| NVAX Novavax | Maintains: Buy | $10 → $11 | $7.13 | +54.28% | 2 | Oct 23, 2025 | |
| DWTX Dogwood Therapeutics | Maintains: Buy | $10 → $12 | $4.24 | +183.02% | 2 | Sep 30, 2025 | |
| AKTX Akari Therapeutics, | Reiterates: Buy | $1.6 | $0.29 | +451.72% | 2 | Sep 9, 2025 | |
| CASI CASI Pharmaceuticals | Reiterates: Buy | $4 | $0.82 | +386.44% | 10 | Sep 3, 2025 | |
| MYO Myomo | Maintains: Buy | $9.5 → $5 | $0.99 | +405.05% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $7.23 | +93.64% | 14 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $66.01 | -39.40% | 10 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.32 | +50.27% | 3 | Mar 26, 2025 |
Kazia Therapeutics
Dec 12, 2025
Maintains: Buy
Price Target: $13 → $18
Current: $5.00
Upside: +260.00%
Cytosorbents
Nov 14, 2025
Maintains: Neutral
Price Target: $1 → $0.75
Current: $0.66
Upside: +14.36%
Senseonics Holdings
Nov 6, 2025
Maintains: Buy
Price Target: $1.4 → $19
Current: $5.89
Upside: +214.09%
Plus Therapeutics
Nov 3, 2025
Maintains: Buy
Price Target: $3 → $2
Current: $0.56
Upside: +260.36%
Alphatec Holdings
Oct 31, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $20.76
Upside: +15.61%
Novavax
Oct 23, 2025
Maintains: Buy
Price Target: $10 → $11
Current: $7.13
Upside: +54.28%
Dogwood Therapeutics
Sep 30, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $4.24
Upside: +183.02%
Akari Therapeutics,
Sep 9, 2025
Reiterates: Buy
Price Target: $1.6
Current: $0.29
Upside: +451.72%
CASI Pharmaceuticals
Sep 3, 2025
Reiterates: Buy
Price Target: $4
Current: $0.82
Upside: +386.44%
Myomo
Aug 12, 2025
Maintains: Buy
Price Target: $9.5 → $5
Current: $0.99
Upside: +405.05%
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $7.23
Upside: +93.64%
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $66.01
Upside: -39.40%
Mar 26, 2025
Reiterates: Buy
Price Target: $11
Current: $7.32
Upside: +50.27%